Abstract:Background: Contrast induced diabetic nephropathy (CIN) is an important cause of hospital-acquired acute renal failure. Our aim was to observe the effect of protein kinase C beta 2 (PKC beta 2) knockdown on human proximal tubular epithelial cells (HK-2 cells) against meglumine diatrizoate and advanced glycation end products (AGEs)-induced apoptosis and autophagy. Methods: Cell viability was detected using cell counting kit-8 (CCK-8) assay in HK-2 cells after disposal with meglumine diatrizoate and AGEs with or without PKC beta 2 siRNA/inhibitor LY333531. Flow cytometry and western blot were used to test cell apoptosis and the related protein levels in meglumine diatrizoate and AGEs co-treated HK-2 cells with or without PKC beta 2 siRNA/inhibitor LY333531. Autophagy related proteins were detected using western blot. Immunofluorescence staining was used to examine the autophagyspecific protein light chain 3 (LC3), and autophagosome and autolysosome formation was observed under a transmission electron microscopy. Results: CCK-8 assay results showed that meglumine diatrizoate inhibited AGEs-induced HK-2 cell viability. Furthermore, meglumine diatrizoate promoted cell apoptosis and the expression level of caspase3 in AGEs-induced HK-2. Western blot results showed that meglumine diatrizoate elevated the expression levels of PKC beta 2 and p-PKC beta 2 in AGEs-induced HK-2 cells, and up-regulated the expression level of Beclin-1 and the ratio of LC3 II/LC3 I, and down-regulated the expression level of p62 in AGEs-induced HK-2 cells. We found that PKC beta 2 knockdown alleviated meglumine diatrizoate and AGEs-induced HK-2 cell apoptosis and autophagy. Intriguingly, PKC beta 2 inhibitor LY333531 reversed 3-methyladenine (3-MA)-induced autophagy inhibition in meglumine diatrizoate and AGEs-induced HK-2 cells. Conclusions: Our findings reveal that inhibiting PKC beta 2 protects HK- 2 cells against meglumine diatrizoate and AGEs-induced apoptosis and autophagy, which provide a novel therapeutic insight for CIN in diabetic patients.

Inhibitory Effect of Kaempferol on Protein Kinase CK2 in vitro and in HL-60 Cells

[Inhibitory Effect and Its Kinetic Analysis of Baicalein on Recombinant Human Protein Kinase CK2 Holoenzyme].

Inhibitory effect of luteolin on recom- binant human protein kinase CK2 holoenzyme in vitro

The Study Of Digitoflavone For The Inhibition Of Protein Kinase Ck2 In Hl-60 Cells

Structure-activity Relationship of 7 Flavonoids on Recombinant Human Protein Kinase CK2 Holoenzyme

Inhibitory Effect of Kaempferol on Proliferation of Human Leukemic Cell HL-60 in Vitro

Inhibiting PKCβ2 protects HK-2 cells against meglumine diatrizoate and AGEs-induced apoptosis and autophagy.

[Effects of Kaempferol and Quercetin on Cytochrome 450 Activities in Primarily Cultured Rat Hepatocytes].

Inhibitory Effect and Kinetic Analysis of 1,8-Dihydroxyanthraquinone on Recombinant Human Protein Kinase CK2 Holoenzyme

Inhibitory Effect and Its Kinetic Analysis of Tyrphostin AG1478 on Recombinant Human Protein Kinase CK2 Holoenzyme.

[Inhibitory Effect and Kinetic Analysis of Sodium Quercetin-7,4'-disulphate on Recombinant Human Protein Kinase CK2 Holoenzyme].

The Effect of Kaempferol on the Proliferation of Human Alveolar Adenocarcinoma Cell Line A549

The Effects of Kaempferol-Inhibited Autophagy on Osteoclast Formation

[Inhibitory Effect of AG1109 on Recombinant Human Protein Kinase CK2 Holoenzyme].

Kaempferol Inhibits Cervical Cancer Cells by Inducing Apoptosis and Autophagy via Inactivation of the PI3K/AKT/mTOR Signaling Pathway

[Kaempferol Activates Human Steroid and Xenobiotic Receptor-Mediated Cytochrome P450 3A4 Transcription].

Supplemental Figure 3 from Kaempferol Targets RSK2 and MSK1 to Suppress UV Radiation-Induced Skin Cancer

Kaempferol attenuates angiotesin II-induced vascular fibrosis involving the jnk and ERK 1 / 2 pathways

Biochemical and cellular mechanism of protein kinase CK2 inhibition by deceptive curcumin

Kaempferol inhibits the proliferation and migration of Epstein-Barr virus-positive diffuse large B-cell lymphoma cells

Effect of kaempferol on the pharmacokinetics of nifedipine in rats]